Skip to main content
$128.54 $1.43 (1.1%)

04:00 PM EDT on 07/23/21

Medtronic (NYSE:MDT)

CAPS Rating: 4 out of 5

Current Price $128.54 Mkt Cap $172.7B
Open $127.57 P/E Ratio 47.94
Prev. Close $128.54 Div. (Yield) $2.52 (2.0%)
Daily Range $127.57 - $128.79 Volume 2,985,482
52-Wk Range $94.64 - $132.30 Avg. Daily Vol. 4,329,928

Caps

How do you think NYSE:MDT will perform against the market?

Add Stock to CAPS Watchlist

All Players

80 Outperform
1 Underperform
 

All-Star Players

24 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:MDT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

RebelHamster (95.01)
Submitted February 05, 2020

Look out for Medtronic. It's not a sexy biotech, but it's a monster.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSE:MDT VS S&P 500 (SPY)

NYSE:MDT Summary

Fools bullish on NYSE:MDT are also bullish on:

Fools bearish on NYSE:MDT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MDT.

Recs

0
Member Avatar kodyk123 (< 20) Submitted: 7/23/2021 2:13:56 PM : Outperform Start Price: $128.59 NYSE:MDT Score: -0.07

Medtronic is positioned to benefit from an aging global population and strong demand for healthcare going forward as a result. The company's commitment to innovation and steady launch of quality products to address serious medical conditions should help deliver mid-single-digit annual revenue growth and high-single-digit annual earnings growth in the years ahead, which will outperform the S&P 500 considering the company is trading near fair value and offers a 2% dividend yield.

Recs

0
Member Avatar TMFjimhalley (35.27) Submitted: 5/31/2021 3:15:42 PM : Outperform Start Price: $127.43 NYSE:MDT Score: -3.24

The company has seen strong growth in revenue in the most recent quarter, meaning that it is poised to do better this year as more medical procedures are performed after a year when they were delayed because of COVID-19. Also, the company's emphasis on diabetes care has trends in its favor.

Recs

0
Member Avatar RLScott (83.34) Submitted: 7/1/2020 10:32:14 PM : Outperform Start Price: $91.41 NYSE:MDT Score: +0.66

Largest Medical Device Maker
Diverse Portfolio
Wide Moat
Excellent Leadership, Omar Ishrak

Leaderboard

Find the members with the highest scoring picks in MDT.

Score Leader

TheNatureBoy41

TheNatureBoy41 (86.35) Score: +13.48

The Score Leader is the player with the highest score across all their picks in MDT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TheFall2021 74.56 12/21/2020 Underperform 5Y $113.56 +13.19% +20.54% +7.35 0 Comment
Gilchrist777 < 20 4/16/2019 Outperform 5Y $83.38 +54.17% +51.21% +2.96 1 Comment
ScratchingBuy 79.86 4/16/2019 Outperform 5Y $83.38 +54.17% +51.21% +2.96 0 Comment
Melsel3 < 20 6/14/2021 Outperform 5Y $122.64 +4.81% +3.97% +0.84 0 Comment
Disciple 70.17 6/29/2020 Outperform 5Y $87.66 +46.64% +45.94% +0.70 0 Comment
RLScott 83.34 7/2/2020 Outperform 5Y $91.41 +40.62% +39.97% +0.66 1 Comment
wasbo008 < 20 7/23/2020 Outperform 5Y $94.93 +35.41% +34.85% +0.56 0 Comment
Atn1027 85.46 8/27/2020 Outperform 5Y $101.39 +26.78% +26.23% +0.54 0 Comment
1Saoirse < 20 8/27/2020 Outperform 5Y $101.39 +26.78% +26.23% +0.54 0 Comment
NancyJean33 93.51 8/27/2020 Outperform 5Y $101.39 +26.78% +26.23% +0.54 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MDT.